Saturday, December 31, 2011
Prevnar 13 Vaccine Expanded for Use in People Ages 50 and Older
The Bay Net

Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.

Pneumococcal pneumonia, caused when the bacterium Streptococcus pneumoniae infects the lungs, is the most common disease caused by this bacterium in adults. When the bacterium invades parts of the body that are normally free from germs, such as the blood or spinal fluid, the disease is considered “invasive.”

“According to recent information for the United States, it is estimated that approximately 300,000 adults 50 years of age and older are hospitalized yearly because of pneumococcal pneumonia,” said Karen Midthun, M.D., director of FDA’s Center for Biologics Evaluation and Research. “Pneumococcal disease is a substantial cause of illness and death. Today’s approval provides an additional vaccine for preventing pneumococcal pneumonia and invasive disease in this age group.”

Sammy 08:37 AM | (0) Comments | Email this post | Permalink
Page 1 of 1 pages

Blog Stats
Registered members: 11238
Number of posts: 61397
Number of Comments: 58291
Last: 11/28/2014 12:05 am
Guests online: 117


Members logged on:
Delusional Duck Feeds
RSS 2.0 RSS 2.0
Atom Feed Atom
Twitter Feed Follow us on Twitter
Facebook Icon Follow us on Facebook

Delusional Duck has been visited 28669909 times. Thanks for supporting us.

Copyright © 2003-2014, Delusional Duck®, All rights reserved. Delusional Duck® is a Registered Trademark.
Comment Policy | Terms of Use | .(JavaScript must be enabled to view this email address)
Home | Discussion Forums